Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KW 2449

Next Previous
X
Search
Drug Profile

KW 2449

Alternative Names: KW-2449

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kyowa Kirin Pharmaceutical Development
  • Developer Kyowa Hakko Kirin; Kyowa Kirin Pharmaceutical Development
  • Class Antineoplastics; Indazoles; Piperazines; Small molecules
  • Mechanism of Action Aurora kinase inhibitors; Bcr-Abl tyrosine kinase inhibitors; Fms-like tyrosine kinase 3 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acute myeloid leukaemia; Chronic myeloid leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 28 Jul 2010 Discontinued - Phase-I/II for Acute myeloid leukaemia in USA (PO)
  • 30 Mar 2010 Suspended - Phase-I/II for Acute myeloid leukaemia in USA (PO)
  • 11 Dec 2007 Interim efficacy, adverse events, pharmacodynamics and pharmacokinetics data from a Phase-I trial and a Preclinical trial in Cancer presented at the 49th Annual Meeting and Exposition of the American Society of Hematology (ASH-2007) ,

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top